Huang James 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-10-29 4:05 pm Purchase | 2024-09-30 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 1,435,000 9.200% | 305,000![]() (+26.99%) | Filing |
2024-06-11 4:10 pm Sale | 2024-06-10 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 1,130,000 8.400% | -1,565,000![]() (-58.07%) | Filing |
2024-01-26 08:31 am Purchase | 2024-01-25 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 2,695,000 19.990% | 268,000![]() (+11.04%) | Filing |
2023-11-09 4:13 pm Purchase | 2023-11-09 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 2,427,000 18.000% | 677,000![]() (+38.69%) | Filing |
2023-06-22 9:15 pm Purchase | 2023-06-16 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 1,750,000 13.000% | 520,000![]() (+42.28%) | Filing |
2023-04-10 11:22 am Purchase | 2023-03-29 | 13G | CASI Pharmaceuticals, Inc. CASI | Huang James | 1,230,000 9.200% | 1,230,000![]() (New Position) | Filing |